Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

RBC Capital Maintains Outperform on CNO Finl Group, Raises Price Target to $30

Author: Benzinga Newsdesk | February 08, 2024 10:51am
RBC Capital analyst Scott Heleniak maintains CNO Finl Group (NYSE:CNO) with a Outperform and raises the price target from $29 to $30.

Posted In: CNO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist